Khalid S. Elaziz-Abd
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pharmacokinetics and safety of TBAJ-587, a novel antimycobacterial diarylquinoline, in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: July 28, 2026
Further elucidation on the effect of food on the pharmacokinetics of trientine.
Journal: European journal of clinical pharmacology
Published: July 21, 2025
New insights into the effects of dissolution profiles on the pharmacokinetics of trientine dihydrochloride.
Journal: European journal of clinical pharmacology
Published: July 21, 2025
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 16, 2025
Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge.
Journal: Journal of clinical medicine
Published: December 23, 2024
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1).
Journal: Cancer chemotherapy and pharmacology
Published: June 27, 2024
Validation of a method for the determination of Aderamastat (FP-025) in K2EDTA human plasma by LC-MS/MS.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: March 17, 2024
Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human study.
Journal: British journal of clinical pharmacology
Published: January 30, 2024
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5.
Journal: Clinical pharmacology in drug development
Published: November 03, 2022
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.
Journal: Neurology and therapy
Published: April 26, 2022
Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study.
Journal: Progress in brain research
Published: February 27, 2021
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects.
Journal: Clinical drug investigation
Published: October 21, 2020
Last Updated: 09/26/2026